Your institution may have access to this item. Find your institution then sign in to continue.
Title
Biodistribution of <sup>18</sup>F-FES in patients with metastatic ER+ breast cancer undergoing treatment with Rintodestrant (G1T48), a novel selective estrogen receptor degrader.